EcoDrugPlus

Ribosomal Protein L18

Ensembl ID : ENSBBBG00000011073
Gene Symbol: RPL18
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSBBBG00000010950
Gene Symbol: RPL18A
3 Cross references
198 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSBBBG00000022817
Gene Symbol: RPL19
3 Cross references
243 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSBBBG00000019345
Gene Symbol: RPL22
3 Cross references
230 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSBBBG00000020616
Gene Symbol: RPL24
3 Cross references
244 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSBBBG00000002476
Gene Symbol: RPL26
3 Cross references
243 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSBBBG00000011783
Gene Symbol: RPL27
3 Cross references
187 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSBBBG00000008604
Gene Symbol: RPL28
3 Cross references
204 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSBBBG00000008662
Gene Symbol: RPL3
3 Cross references
264 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSBBBG00000013116
Gene Symbol: RPL30
3 Cross references
228 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSBBBG00000002148
Gene Symbol: RPL32
3 Cross references
231 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSBBBG00000014980
Gene Symbol: RPL35
3 Cross references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).